Guiding Oncology Therapies from Early Detection of Response to Approval
Partner with a collaborative oncology CRO
that believes in your research as much as you do.
We Have You Covered Throughout Every Phase
Clinical Trial Services
Preclinical
Regulatory Support
Flow Cytometry
The TD2 Oncology Ecosystem
At TD2, we are revolutionizing oncology research through an integrated ecosystem that brings together preclinical services, advanced flow cytometry, robust regulatory support, an extensive site network, and comprehensive clinical trial services. Our mission is to accelerate the development of innovative cancer therapies.
Learn moreAccelerating Cancer Drug Development
Since 2003, TD2 has made an impact beyond what is expected of a traditional oncology CRO. Not only do we work with hundreds of biotech and pharma companies to rapidly move new therapy discoveries to market through proactive problem solving and strategic collaboration, but we are also drug development innovators. The breadth of our services gives us the unique ability to translate scientific hypotheses generated in a lab setting into patient responses in the clinic. Our results consistently outpace our competition due to a dynamic, flexible and highly specialized team that is laser-focused on oncology.
meet our teamCONTACT US
Work with a team who believes in your research as much as you do.
Are you ready to move your cancer therapy to market? Partner with a collaborative oncology CRO that believes in your treatment as much as you do. Take the first step today and contact our experts.
Latest blog Posts
- Flow Cytometry Processing and Analysis of Tumor Specimens: Testing Viability and Staining Post ShippingPreclinical|January 9, 2025
- The Importance of Conducting PDX Oncology Studies in a Humanized Immune SystemPreclinical|December 18, 2024
- Leveraging Flow Cytometry to Drive Better Patient Outcomes in Hematologic Malignancy Clinical TrialsClinical|December 10, 2024